8-K
Current Report
Tarsus Pharmaceuticals, Inc. Filed Acc 0001193125-22-178792
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d301085d8k.htm…